drugset
drugset / Trial / NCT02025270

MSCs For Treatment of Azoospermic Patients

NCT02025270 ↗

Phase 1/2 Completed 100 enrolled Al-Azhar University Cairo University · collab
RandomizedSingle-groupSingle-blindTreatment

Summary

In this study, we performed autologous BMDMSC transplantation to the testis of Azoospermic patients in a trial to enhance and activate the spermatogonial stem cells of the testis and aiming to produce motile sperm.

Timeline

Start
2012-10-15
Primary completion
2016-10-15
Completion
2022-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy 5 ml Other

Indications

male infertility